NFKB1 and inflammatory response: Jung et al. for the first time found that CTRP9 could decrease the expression of NF-κB-mediated proinflammatory genes and attenuate the cytokine-induced vascular inflammation via the AMP-activated protein kinase (AMPK) way [15].